Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood vessel damage
Show results for
Products

Companies

News
Articles

Refine by
Date

  • Older

Blood Vessel Damage Articles & Analysis

9 news found

Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years

Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years

About DME Diabetic macular edema (DME) is a common complication in eyes of people living with diabetes. DME occurs when high levels of blood sugar lead to damaged blood vessels in the eye that leak fluid into the macula. ...

ByBayer AG


New data from pivotal studies with aflibercept 8 mg

New data from pivotal studies with aflibercept 8 mg

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Effectiveness of the picosecond laser and the precautions after treatment

Effectiveness of the picosecond laser and the precautions after treatment

Picosecond technology penetrates deep into the skin and acts on the skin or blood vessels, causing the damaged tissue to atrophy and die, resulting in darkening and crusting of the skin. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Bayer submits aflibercept 8 mg for marketing authorization in Japan

Bayer submits aflibercept 8 mg for marketing authorization in Japan

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Revacept protects during carotid artery surgery

Revacept protects during carotid artery surgery

All patients required therapy because of dangerous narrowing of the carotid artery and received the nowadays standard basic therapy with the blood platelet inhibitors acetylsalicylic acid (Aspirin©) and/or clopidogrel to prevent renewed vascular occlusion (thrombosis). ...

ByadvanceCOR GmbH


Detailed data from pivotal studies with aflibercept 8 mg demonstrate sustained improvements in visual acuity and anatomic measures with large majority of patients maintaining treatment intervals of 16 weeks at week 48

Detailed data from pivotal studies with aflibercept 8 mg demonstrate sustained improvements in visual acuity and anatomic measures with large majority of patients maintaining treatment intervals of 16 weeks at week 48

About nAMD and DME Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood ...

ByBayer AG


Leonhardt’s Launchpads Accelerator to Showcase Eight Innovation Assets and Startups At 2022 Demo Day

Leonhardt’s Launchpads Accelerator to Showcase Eight Innovation Assets and Startups At 2022 Demo Day

The 2021 class of Leonhardt’s Launchpads Accelerator graduates include: MyoStim ED with ErectiStimTM: MyoStim ED is the first intervention for erectile dysfunction (ED) designed to address all major causes of ED: impaired blood flow, damaged blood vessels, nerve damage, and muscle deterioration. MyoStim ...

BySecond Heart Assist, Inc.


Aircraft noise at night can result in dysfunction of blood vessels and cause long-term cardiovascular disease

Aircraft noise at night can result in dysfunction of blood vessels and cause long-term cardiovascular disease

Recent research into the impact of different levels of noise on 75 volunteers reveals that disturbed sleep caused by night-time aircraft noise can damage blood vessels and increase the levels of stress hormones. As these physical changes are potential pathways to high blood pressure, heart and circulatory disease over the long ...

ByEuropean Commission, Environment DG

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT